Browse by Track

(C12) Genotyping, Echocardiographic Screening, and Whisker Papilla Fibroblast Collection in Purebred Maine Coon and Ragdoll Cats

(C23) Agreement Between Doppler Ultrasound and High-definition Oscillometric Device for Systolic Arterial Pressure in Hospitalized Dogs

(C27) Serial Evaluation of Left Ventricular Systolic Function in Dogs Undergoing Chemotherapy with Doxorubicin

(C28) Procedural Surgical Protocol for Canine Mitral Valve Repair

(C29) Retrospective Evaluation of Sacubitril/valsartan (Entresto) in 20 Dogs with Advanced Congestive Heart Failure

(C30) Case Series of Six Dogs with Primary Tricuspid and Right Ventricular Outflow Tract Neoplasms

(C31) Retrospective Evaluation of the Effect of Sotalol on Survival in Dogs with Severe Subaortic Stenosis

(C32) Effect of Autologous Blood Collection for Mitral Valve Repair on Hemodynamics and Cardiac Function

(C33) Tissue Renin-angiotensin System Enzyme Activity in Canine Post-mortem Myocardial and Kidney Samples

(C34) Cardiovascular Abnormalities in Dogs with Acute Pancreatitis

(C35) Chronic Myxomatous Valve Disease Prevalence and Pathologic Features. Canine Mitral, Tricuspid, Aortic, and Pulmonic Valves

(C36) International Evaluation of Clinical Characteristics and Outcomes in 137 Dogs with Reverse Patent Ductus Arteriosus

(C37) Multivariate Statistical Analysis in the Screening of Subclinical Hypertrophic Cardiomyopathy Phenotype in Domestic Cats

(C38) Hypertensive Cardiomyopathy in Dogs: Echocardiography and Sex Differences

(C39) Mitral Annular Plane Systolic Excursion in Dogs with Systemic Arterial Hypertension

(C40) QT Interval, Electrolyte and Acid-Base Evaluation in Dogs with Chronic Kidney Disease

(C41) Validation of a Point-of-Care Quantitative Assay for Feline NT-proBNP

(C42) Cartilage Intermediate Layer Protein 1 as a Novel Biomarker for Canine Myxomatous Mitral Valve Degeneration

(C43) Intrarenal Venous Flow Analysis by Ultrasound in Dogs with Heart Disease

(C44) High Prevalence and Clinical Features of Mitral Regurgitation in Young Chihuahuas Without Heart Murmurs

(C45) Plasma Serotonin, Endothelin and VEGF-D: A Differential Marker of Pre- and Postcapillary Pulmonary Hypertension

(C46) Prognostic Value of Left Atrial Stiffness Estimated Using Echocardiography in Canine Myxomatous Mitral Valve Disease

(C48) Clinical Outcome of Idiopathic Juvenile Ventricular Arrhythmias in 25 Dogs

(C49) Echocardiographic Comparison of Right Ventricular Function Between Dogs with Pre- and Post-capillary Pulmonary Hypertension

(C50) Up-regulation of STATs and IRF-1 in Canines with Heart Murmur and Associated Valvular Cardiovascular Disorder

(C51) Serum Carnitine Profile of Cats with Hypertrophic Cardiomyopathy

(C52) Taurine Concentrations in Cavalier King Charles Spaniels: Reference Intervals, Diet, and Mitral Valve Disease Effects

(C53) Peripheral Edema in Dogs: Clinical Characteristics and Etiologies

(C54) Effect of Beraprost on Hemodynamics and Cardiac Function in Dogs with Pulmonary Hypertension

(C56) Echocardiographic Assessment of Cardiac Function in Dogs with Pulmonary Hypertension Secondary to Respiratory Disease

(C57) Transesophageal Echocardiography-Related Complications During Mitral Valve Repair in Dogs

(E04) Assessment of the Hypothalamic-pituitary-adrenocortical Axis Function Utilizing a Vasopressin Stimulation Test in Healthy Foals

(E05) The Enteroinsular Axis in Hospitalized Foals with Gastrointestinal Disease

(E06) Attenuation of Post-prandial Hyperglycemia by 5’-adenosine Monophosphate-activated Protein Kinase Agonists in Experimentally-induced Equine Insulin Dysregulation

(E15) How Sedation and Recumbency Influence Distribution of Ventilation Measured by Electrical Impedance Tomography in Foals

(E16) Clinical Findings and Outcome Predictors for Equine Multinodular Pulmonary Fibrosis: 46 Cases (2009-2019)

(E17) Developing a Tool to Detect and Track Laryngeal Dysfunction in Horses

(E18) Seasonal Assessment of Serum 25-Hydroxyvitamin-D concentrations in Healthy and Asthmatic Horses

(E23) Equine Hyperinsulinemia Causes Tissue-Specific Alterations of Cytokines and Acute Phase Proteins in a NDkB-independent Manner

(E24) Effect of Phenylbutazone Administration on Insulin and Glucose Dynamics in Horses

(E25) Prospective Assessment of Clinical Signs and ACTH Concentrations in Horses Transitioning to PPID

(E26) Seasonal Effects of Plasma ACTH in Horses and Donkeys Residing Near the Equator

(E27) Effects of Latitude, Age and Season on Equine Adrenocorticotropic Hormone Concentrations in the United States

(E28) Comparison of a Newly Developed Glycemic Pellets Challenge with the Oral Sugar Test in Horses

(E29) Effect of AMPK Agonists on Hepatic Lipid Content in Horses with Experimentally-induced Insulin Dysregulation

(E30) Effect of High-carbohydrate Feeding and Corticosteroid Administration on Lipid Content of Equine Liver

(E31) Effects of Dopamine Suppression on Postprandial Glucose and Insulin Responses to Glucose Feeding in Horses

(E32) The Effect of Trailering on Thyrotropin Releasing Hormone Stimulation of Adrenocorticotropic Hormone Concentration in Horses

(E33) A Combined Procedure to Identify Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation in Horses

(E34) Dynamic Insulin Responses to High Carbohydrate Diet Acclimation in Normal and Insulin Dysregulated Horses

(E37) Fecal Microbiota of Diarrheic Horses and Its Association with Laminitis

(E38) Right Dorsal Colitis in Horses: A Retrospective Study of 35 Cases

(E39) Ultrasonographic Assessment of Small Intestinal Motility Following Hyoscine Butylbromide Administration in Horses

(E40) Effect of Post-Operative Reflux on Survival of Horses with Large Colon Volvulus

(E41) Post-mortem Prevalence of Gastric Ulceration in Diarrheic Horses

(E42) Bacterial Viability in Different Preparation Protocols of Fecal Microbiota Transplantation Solution

(E43) Bacterial Translocation in Horses with Colic Addressed by DNA Sequencing

(E44) The Fecal Bacterial Microbiota in Healthy and Sick Neonatal Foals

(E50) Use of CRISPR-SeroSeq to Detect Multiple Salmonella Serotypes in Equine Fecal Samples

(E51) MALDI-TOF Mass Spectrometry for Improved Identification of Equine Bacterial Isolates

(E52) SARS-CoV-2 Pseudovirus Infects Equine Bronchial Epithelial Cells In Vitro

(E56) Pain Scoring Systems for Predicting Clinical Outcomes In Hospitalized Equine Ophthalmology Patients

(E57) Effects of Equine Platelet Lysate on ex-vivo Vasculogenesis

(E58) Transdermal EMLA (lidocaine/prilocaine) Cream for Intravenous Catheterisation in Horses

(E59) Pharmacokinetics of Single Dose Administration of 20 and 40 mg/kg of Acetaminophen in Neonatal Foals

(E60) Detection of Oxycodone Metabolites in Plasma After Oral Administration to Horses.

(E62) Electrical Impedance Tomography Can Determine Airflow in the Respiratory System of Healthy Adult Horses

(E64) An Updated Description of Bacterial Pneumonia in Adult Horses and Factors Associated with Non-survival

(E65) Utility of Serum Amyloid a in Monitoring Response to Antimicrobial Therapy in Equine Pneumonia

(E67) Comparative Efficacy and Adverse Effects of Salbutamol and N-butylscopolammonium Bromide in Horses with Severe Asthma

(F03) Blood Cultures and Outcomes in Sick Neonatal Beef Calves

(F04) Pathogen-Specific Intramammary Infection Prevalence, Persistence, and Somatic Cell Count Association in Lactating Jersey Cows

(F05) Left Ventricular Systolic Function in Neonatal Calves With Diarrhea

(F06) The Association Between Fecal Microbiota, Endoparasitism and Age of Adult Alpacas

(F07) Minimum Colostral Immunoglobulin G Concentration Required for Pooling to Achieve Adequate Immunity in Dairy Calves

(F09) Fecal Microbiota of Diarrheic Calves and Its Association with Acid-base Disorders

(F11) Associations Between Measured Climate Parameters, Barn Characteristics, and Health Indicators in Swiss Veal Calf Herds

(F12) Detection Times of Florfenicol/florfenicol Amine in Lactating Meat and Dairy Goats, and Milk Fed Kids

(F13) The Pharmacokinetics and Clinical Efficacy of Levamisole in Adult Alpacas after Oral Administration

(N08) Current Practices in the Diagnosis and Management of Dogs with Degenerative Myelopathy: A Questionnaire-Survey

(N09) A Novel Technique for Measuring Spasticity in Dogs After Acute Thoracolumbar Intervertebral Disc Extrusion (TL-IVDE)

(N10) Thoracic Vertebrae: Proximity to Vital Structures and Implantation Corridor Measurements

(N15) Alpha-Chloralose Poisoning in Cats: Clinical Presentation in 24 Confirmed Cases

(N17) Electroencephalogram and Heart Rate Variability Changes After Transcutaneous Vagus Nerve Stimulation in Healthy Dogs

(N18) Expression of Hyperphosphorylated Tau in Dogs with Immune-mediated Meningoencephailitis

(N19) Ondansetron in Dogs with Vestibular Nausea: A Double-blinded, Randomized, Placebo-controlled Crossover Study

(N20) Towards a Mobile App for Automated Pain Assessment in Cats using Deep Learning

(N21) Neutrophil-to-Lymphocyte Ratio as a Diagnostic Marker in Dogs with Meningoencephalitis of Unknown Etiology

(N22) Effects of Trazodone Administration on the Neurologic Examination in Healthy Dogs

(N23) Neurofilament Light Chain Concentrations in Dogs with Meningoencephalomyelitis

(N24) Functional Connectivity Magnetic Resonance Imaging in Dogs Anesthetized with Dexmedetomidine and Propofol

(N26) Retrospective Review of Nerve Root Signature Associated with Cervical Intervertebral Disc Disease in Dogs

(N27) Spinal Cord and Dural Sac Termination and Morphometry in Different Dog Breeds.

(NM02) Comparing Dried Blood Spot and Lateral Flow testing to Serum 25-hydroxyvitamin D Concentrations in Cats

(NM03) Hyperhomocysteinemia and Oxidative Stress in Greyhound Dogs

(NM04) The Effects of Storage Temperature and RNAlater Solution on the Canine Fecal Microbiota

(NM07) Repertoriating Raw Food Companies in Quebec for Domestic Animals

(NM08) Evaluating the Causes and Consequences of Canine Food Motivation Within the Dog Aging Project Pack

(NM09) Efficacy and Tolerability of a Novel Phosphate Binder Supplement in Cats

(NM10) Low Carbohydrate Diet Reduces Circulating Inflammatory Gene Expression in Dogs with Chronic Gastroenteritis

(NM11) Implications of COVID-19 Pandemic in the Feeding Habits of Dogs Domiciled in São Paulo, Brazil

(O02) Cytomorphologic Changes in Blood Leukocytes and Erythrocytes in Dogs Receiving CHOP Treatment for Multicentric Lymphoma

(O05) Fibrinogen Degradation Products as a Clinical Biomarker for Cancer Diagnosis and Prognosis in Neoplastic Dogs

(O14) Do Dogs Get Cancer-Associated Thrombosis? Retrospective Analysis of Characteristics of Dogs with Thrombosis: 2014-2019

(O15) Anti-cancer Effects of Oral Paclitaxel Against Canine Mammary Gland Cancer

(O16) Anticancer Activity of IRAK-4 Inhibitors Against Canine Lymphoid Malignancies

(O17) Evaluation of a Novel Blood Test for the Detection of “Difficult to Diagnose” Cancers

(O18) Identification of the Potential Candidate Genes and Signaling Pathways Involved in Lymphoma Progression in Dogs

(O19) Pilot Study of Partial Ablation with Mechanical High-Intensity Focused Ultrasound (Histotripsy) in Dogs with Spontaneously Occurring Soft Tissue Sarcomas (VCS Award Winner)

(P06) Reversal of the Effects of a Medetomidine-vatinoxan Combination Drug (Zenalpha) with Atipamezole

(P07) Clinical Audit of POM-V/POM Prescriptions by Remote Consultation via a Veterinary Video Telemedicine Smartphone Application

(P08) Plasma Pharmacokinetics of a Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor (Molidustat) in Healthy Cats

(P09) Fluconazole Has Variable Oral Systemic Absorption in Dogs

(P10) Voluntary Acceptance of Compounding Flavors in Cats

(R06) Effectiveness of Pediatric Inhaler Chambers in Cats with Asthma

(R07) Study of Nasal Microbiome in Dogs with Nasal Diseases and Healthy Dogs

(EN03) Effect of Ethylenediaminetetraacetic Acid and Magnesium Chloride on Measurement of Canine Adrenocorticotropic Hormone

(EN05) Assessment of the FreeStyle Libre 2 Interstitial Glucose Monitor in Hypo- and Euglycemia in Cats

(EN06) Sterility of Refrigerated, Multidose Insulin Vials Through 6 Months of Use

(EN13) A Modified Oral Glucose Tolerance Test Detects Mild Dysglycemia Caused by Capromorelin

(EN20) Variability Between Two Flash Glucose Sensor Locations in Non-Diabetic Dogs During Rapidly Induced Hypoglycemia

(EN21) Geographic Prevalence of Naturally Occurring Feline Hyperthyroidism

(EN22) Diagnosis of Canine Hyperadrenocorticism Using a Point-of-Care Cortisol Assay

(EN23) Evaluation of a Flash Glucose Monitoring System in Diabetic Cats.

(GI07) Relationship between Magnesium, Calcium, and Parathyroid Concentrations in Dogs with Decreased 25(OH)D and Chronic Enteropathy

(GI14) Characterisation of the Culturable Duodenal Mycobiota of Dogs with Chronic Enteropathy

(GI23) Placebo Controlled Trial of Hydrolyzed Fish Diets in Dogs With Chronic Enteropathy

(GI27) Prevalence of Clostridioides difficile in Canine Feces and Its Association with Dysbiosis

(GI28) A Randomized Non-Controlled Open-Label Trial in Cats Comparing Cyclosporine and Prednisolone for Treating Chronic Pancreatitis

(GI29) Histopathologic Examination of Serial Pancreatic Sections from Shelter Cats

(GI30) Characterizing the Serum Proteome of Cats with Chronic Enteropathy

(GI31) Microbiome Responses to Fecal Microbiota Transplantation in Cats

(GI32) Food-responsive Enteropathy Occurrence in Dogs with Chronic Enteropathy in São Paulo-Brazil.

(GI33) Retrospective Evaluation of the Risk of Gastrointestinal Bleeding in Dogs Receiving Ophthalmic Non-steroidal Anti-inflammatory Drugs

(GI34) Oxidative Stress in Dogs with Acute Pancreatitis

(HM04) Investigation of Novel Hemostasis Parameters and Closure Curves on the Platelet Function Analyzer-200 in Cats

(HM05) Validation of Shipping of Feline Blood Samples for Analysis on the Platelet Function Analyzer 200

(HM06) Validation of the ProCyte Dx and Visual Slide Review with the Plateletworks System in Cats

(HM08) Assessing Methods to Monitor Rivaroxaban Therapy in Hypercoagulable Dogs

(HM10) Retrospective Analysis of Immunosuppressive and Anti-thrombotic Protocols in Canine Non-associative Immune-mediated Hemolytic Anemia

(HM11) Differences in Hematological Parameters Between Dogs with Congenital Intrahepatic and Extrahepatic Portosystemic Shunts

(HM12) Evaluation of Thrombin Generation as a Novel Antiplatelet Therapeutic Monitoring tool in Dogs administered Clopidogrel

(HM13) Comprehensive Protein and Gene Expression Analysis of Spleen from Dogs with Non-regenerative Immune-mediated Anemia

(HP07) Demographic and Histopathologic Associations with Elevated Hepatic Copper Concentrations in Dogs

(HP08) Clinical Use of Ursodiol in Feline Medicine

(HP09) Retrospective Review of Clinical Presentation, Survival and Response to Therapy in Dogs with Granulomatous Hepatitis

(ID03) Effect of Urine Concentration on the Growth of Canine Uropathogens: An in Vitro Study

(ID09) Molecular Identification of Hemoparasites of Dogs in the Western Amazon

(ID10) Proteinuria in Dogs with Pulmonary Coccidioidomycosis

(ID11) Differentiating Giardia Duodenalis Assemblages with a Novel Beta-giardin PCR Assay

(ID12) Evaluation of Leptospira Exposure in Feral Cat Populations in Northern California and Southern Texas

(IM04) Relapse Risk Factors for Immune Mediated Hemolytic Anemia: A Retrospective Study of 223 Dogs

(IM05) Use of a Flow Cytometry Assay to Detect Anti-erythrocyte Antibodies in 116 Anemic Client-owned Dogs

(IM06) The Intestinal Microbiome of Dogs with Immune-mediated Hemolytic Anemia or Immune Thrombocytopenia

(IM07) Romiplostim in Primary and Secondary Thrombocytopenia: A Retrospective Study of Dogs and Cats

(IM08) Anti-oxidative and Immunomodulatory Effects of Telmisartan in Healthy Cats

(NU01) Evaluation of Creatinine, Symmetric Dimethylarginine, Kidney Injury molecule-1 and Glomerular Filtration Rate in Healthy Cats

(NU05) Evaluation of Health-Related Quality of Life in Cats with Chronic Kidney Disease

(NU06) Safety and Efficacy of Nightly, Prophylactic Nitrofurantoin in 14 Dogs with Recurrent Urinary Tract Infections

(NU17) Urinary Glutathione Peroxidase 4 in Cats with Naturally Occurring Chronic Kidney Disease

(NU18) Non-Transferrin-Bound Iron in Cats with Naturally Occurring Chronic Kidney Disease

(NU19) Diltiazem Infusion Alterations on Glomerular Filtration Rate, Electrolyte Excretion, and Urine Output in Healthy Dogs

(NU20) Urinary Angiotensin-Converting Enzyme 2 Concentration and Activity in Cats with Naturally Occurring Chronic Kidney Disease

(NU21) Pilot Field Study of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor in Chronic Kidney Disease-Associated Anemic Cats

(NU22) Apolipoprotein B100 Is a Potential Urine Biomarker for Membranoproliferative Glomerulonephritis in Dogs with Protein-losing Nephropathy

(NU23) Electrophoretic Urine Protein Banding Patterns as a Diagnostic Biomarker for Canine Membranoproliferative Glomerulonephritis

(NU24) Benign Feline Ureteral Obstruction: Outcome of Cats Undergoing Medical Management

(NU26) Urinary Clusterin and Cystatin B Concentrations in Dogs with Kidney Disease

(NU27) Urinary Cystatin B Differentiates Progressive versus Stable Stage I Chronic Kidney Disease in Dogs

(NU28) Mineralocorticoid Receptor Expression and Activation in Feline Chronic Kidney Disease and Associations with Disease Progression

(NU30) Untargeted Metabolomic Profiling of Serum from Cats with Chronic Kidney Disease

(NU31) Reduced Antioxidant System and Increased Inflammation in Canines with Chronic Kidney Disease

(NU32) Evaluation of Novel Renal Injury Markers in Dogs with Ehrlichiosis.

(NU33) C-Reactive Protein and Canine Ehrlichiosis: A New Clinical Perspective

(NU34) Effect of Tamsulosin on Urethral Tone in Healthy Male Cats

(NU35) Serum Concentrations of Leptin and Adiponectin in Dogs with Chronic Kidney Disease

(OT01) Using End-of-Life Survey to Investigate the Relationship between Quality-of-Life, Manner and Location of Death

(OT11) End of Life Survey - Free Text Analysis